Diagnostic and therapeutic approach to hypothalamic amenorrhea

Annals of the New York Academy of Sciences

Volumn 1092, Issue , 2006, Pages 103-113

  Genazzani, Alessandro D ^a   Ricchieri, Federica ^a   Lanzoni, Chiara ^a   Strucchi, Claudia ^a   Jasonni, Valerio M ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

GnRH; Hypoestrogenism; Hypogonadotropic amenorrhea; Hypothalamic amenorrhea; Stress; Weight loss; endorphin

Indexed keywords

LEVACECARNINE; NALTREXONE; PIVAGABINE;

AMENORRHEA; ANAMNESIS; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; EATING DISORDER; HOMEOSTASIS; HUMAN; HYPOTHALAMIC AMENORRHEA; MENARCHE; MENSTRUAL CYCLE; MENTAL STRESS; METABOLIC STRESS; NONHUMAN; PHYSICAL STRESS; PROTEIN DIET; SECONDARY AMENORRHEA; WEIGHT REDUCTION; FEMALE; HYPOTHALAMUS DISEASE; PATHOPHYSIOLOGY; REVIEW;

AMENORRHEA; FEMALE; HUMANS; HYPOTHALAMIC DISEASES;

EID: 34247229642     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1365.009     Document Type: Conference Paper

References (53)

1. BATRINOS, M.L., C. PANITSA-FAFLIA, N. COURCOUTSAKIS & V. CHATZIPAVLOU. 1990. Incidence, type, and etiology of menstrual disorders in the age group 12-19 years. Adolesc. Pediatr. Gynecol. 3: 149-153.
2. FRISCH, R.E. & J.W. MCARTHUR. 1974. Menstrual cycles: fatness as a determinant of minumun weight for height necessary for their maintenance or onset. Science 185: 949-951.
3. VELDHUIS, J.D., W.S. EVANS & L.M. DEMERS. 1985. Altered neuroendocrine regulation of gonadotropin secretion in women distance runners. J. Clin. Endocrinol. Metab. 61: 557-562.
4. CAMERON, J.L., D.L. HELMREICH & D.A. SCHREIHOFER. 1993. Modulation of reproductive hormone secretion by nutritional intake: stress signals versus metabolic signals. Hum. Reprod. 8: 162-167.
5. FACCHINETTI, F., M. FAVA, L. FIORONI, et al. 1993. Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. Psychoneuroendocrinology 18: 397-404.
6. CANNAVO, S. & F. TRIMARCHI. 2001. Exercise-related female reproductive dysfunction. J Endocrinol Invest 24: 823-832.
7. AMERICAN PSYCHIATRIC ASSOCIATION. 1995. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association. Washington, DC.
8. GENAZZANI, A.D., F. PETRAGLIA, G. FABBRI, et al. 1990. Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss. Fertil. Steril. 54: 222-226.
9. VIGERSKY, R.A., A.E. ANDERSEN, R.H. THOMPSON & D.L. LAURIAUX. 1977. Hypothalamic dysfunctuion in secondary amenorrhea associated with weight loss. N. Engl. J. Med. 297: 1141-1146.
10. BERGA, S.L., S.F. MORTOLA, L. GIRTON, et al. 1989. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 68: 301-308.
11. GENAZZANI, A.D., F. PETRAGLIA, M. GASTALDI, et al. 1993. FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile and postmenopausal women. Am. J. Physiol. 264: E776-E781.
12. GENAZZANI, A.D., F. PETRAGLIA, R. BENATTI, et al. 1991. Luteinizing hormone (LH) secretory burst duration is independent from LH, prolactin, or gonadal steroid plasma levels in amenorrheic women. J. Clin. Endocrinol. Metab. 72: 1220-1225.
13. GENAZZANI, A.D., F. PETRAGLIA, M. GASTALDI, et al. 1994. Episodic release of prolactine in women with weight loss releated amenorrhea. Gynecol. Endocrinol. 8: 95-100.
14. FIORONI, L., M. FAVA, A.D. GENAZZANI, et al. 1994. Life events impact in patients with secondary amenorrhea. J. Psychosom. Res. 6: 617-622.
15. QUIGLEY, M.E., K.L. SHEEHAN, R.F. CASPER & S.S. YEN. 1980. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea. J. Clin. Endocrinol. Metab. 50: 949-954.
16. PETRAGLIA, F., A.E. PANERAI, C. RIVIER, et al. 1988. Opioid control of gonadotropin secretion. In Brain and Female Reproductive Function. A.R. Genazzani, U. Montemagno, C. Nappi, F. Petraglia, Eds.: 65-72. Parthenon. Carnforth, UK.
17. RIVIER, C., V. RIVIER & W. VALE. 1986. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Science 231: 607-609.
18. PETRAGLIA, F., S. SUTTON, W. VALE & P. PLOTSKY. 1987. Corticotropin-releasing factor decrease plasma luteinizing hormone levels in female rats by inhibiting gonadotropin-releasing hormone release into hypophyseal portal circulation. Endocrinology 120: 1083-1088.
19. PETRAGLIA, F., W. VALE & C. RIVIER. 1986. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat. Endocrinology 119: 2445-2450.
20. NAPPI, R.E., F. PETRAGLIA, A.D. GENAZZANI, et al. 1993. Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. Fertil. Steril. 59: 571-576.
21. RINGSTROM, S.J., D. SUTER, J. D'AGOSTINO, et al. 1991. Effects of glucocorticoids on the hypothalamic-pituitary- gonadal axis. In Stress and Related Disorders from Adaptation to Dysfunction. A.R. Genazzani, G. Nappi, F. Petraglia and E. Martignoni, Eds.: 297-305. Parthenon. Carnforth, UK.
22. KAMEL, F. & C.L. KUBAJAK. 1987. Modulation of gonadotropic secretion by corticosterone interaction with gonadal steroids and mechanism of action. Endocrinology 121: 561-568.
23. GALA, R.R. 1990. The physiology and mechanisms of stress-induced changes in prolactine secretion in rat. Life Sci. 46: 1407-1410.
24. BLAZEJ, M., A. TONETTI, P. MONTELEONE, et al. 2000. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropinreleasing hormone test. Eur. J. Endocrin. 142: 280-285.
25. ONOFRJ, M., I. BODIS-WOLLNER, P. POLA & M. CALVANI. 1983. Central cholinergic effects of levo-acetyl-carnitine. Drugs. Exp. Clin. Res. 9: 161-167.
26. JANIRI, L. & E. TEMPESTA. 1983. A pharmacological profile of the effects of carnitine and acetyl-L-carnitine on the central nervous system. Int. J. Clin. Pharmacol. Res. 3: 295-306.
27. TEMPESTA, E., L. JANIRI, C. PIRRONCELLI. 1985. Stereospecific effects of acetyl-L-carnitine on the spontaneous activity of brain stem neuronesa and their responses to acethylcoline and serotonin. Neuropharmacology 24: 43-50.
28. TESTA, G. & C. ANGELINI. 1981. A preliminary trial with acetyl-L-carnitine (A-Cn) in dementia. Current Reports in Neurology 5: 4-16.
29. KRSMANOVIC, L.Z., M.A. VIRMANI, S.S. STOJIKOVIC & K.J. CATT. 1992. Actions of acetyl-L-carnitine on gonadotrophin secretion. Gynecol. Endocrinol. 6 (Suppl 1): 11.
30. QUIGLEY, M.E. & S.S.C. YEN. 1980. The role of endogenous opiates on LH secretion during the menstrual cycle. J. Clin. Endocrinol. Metab. 51: 179-181.
31. PETRAGLIA, F., G. D'AMBROGIO, G. COMITINI, et al. 1985. Impairment of opiod control of luteinizing hormone secretion in menstrual disorders. Fertil. Steril. 43: 535-540.
32. PETRAGLIA, F., C. PORRO, F. FACCHINETTI, et al. 1986. Opioid control of LH secretion in humans: menstrual cycle, menopause and aging reduce effect of naloxone but not of morphine. Life Sci. 38: 2103-2110.
33. GENAZZANI, A.D., F. PETRAGLIA, I. ALGERI, et al. 1991. Acetyl-L-carnitine as possible drug in the treatment of hypothalamic amenorrhea. Act. Obstet. Gynecol. Scand. 70: 487-492.
34. WILDT, L., G. LEYENDECKER, T. SIR- PETERMANN & S. WAIBEL-TREBER. 1993. Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy. Hum. Reprod. 8: 350-358.
35. GENAZZANI, A.D., F. PETRAGLIA, M. GASTALDI, et al. 1995. Naltrexone treatment restores menstrual cycles in patients with weight loss related amenorrhea. Fertil. Steril. 64: 951-956.
36. BIGGIO, G., E. SANNA, M. SERRA, E. COSTA. 1995. GABAa receptors and anxiety. In Advances in Biochemistry and Psychopharmacology, G. Biaggio, vol 48. Raven Press, New York, NY.
37. BIGGIO, G., A. CONCAS, M.G. CORDA, et al. 1990. GABAergic and dopaminergic trasmission in the rat cerebral cortex: effect of stress, anxiolytic and anxiogenic drugs. Pharmacol. Ther. 48: 121-142.
38. CONCAS, A., M. SERRA, T. ATSOGGIU & G. BIGGIO. 1988. Foot shock and anxuiogenic beta-carbolines increase t-[35S]-butylbicyclophosphorotionate binding in the rat cerebral cortex, an effect opposite to anxiolytic and gamma-aminobutyric acid mimetics. J. Neurochem. 51: 1868-1876.
39. KALOGERAS, K.T., A.E. CALOGERO, T. K URIBAYIASHI, et al. 1990. In vitro and in vivo effects of triazolobenzodiazepine alprazolam and hypothalamic-pituitary-adrenal function: pharmacological and clinical implications. J. Clin. Endocrinol. Metab. 70: 1462-1471.
40. IMAKI, T. & W. VALE. 1993. Chordiazepoxide attenuates stress-induced accumulation of corticotropin releasing factor mRNA in paraventricularnucleous. Brain Res. 623: 223-228.
41. IMAKI, T., W. XIAO-QUAN, Y. SHIBASAKI, et al. 1995. Chlordiazepoxide attenuates stress-induced activation of neurons, corticotropin-releasing factor (CRF), gene transcription and CRF biosynthesis in the paraventricular nucleus (PVN). Mol Brain Res. 32: 261-270.
42. GALZIGNA, L., L. GARBIN, M. BIANCHI & A. MARZOTTO. 1978. Properties of two derivatives of gamma-aminobutyric acid (GABA) capable of abolishing Cardiazol- and bicuculline-induced convulsions in the rat. Arch. Int. Pharmacodyn. Ther. 235: 73-85.
43. ESPOSITO, G. & M.R. LUPARINI. 1997. Pivagabine: a novel psychoactive drug. Arzneim Forsch Drug Res. 47: 1306-1309.
44. SERRA, M., A. CONCAS, M.C. MOSTALLINO, et al. 1999. Antagonism by pivagabine of stress-induced changes in GABAa receptor function and corticotropin-releasing factor concentrations in rat brain. Psychoneuroendocrinology 24: 269-284.
45. M. FERIN. 1999. Stress and the reproductive cycle. J Clin Endocrinol Metab 84: 1768-1774.
46. CAMERON, J.L. 1996. Regulation of reproductive hormone secretion in primates by short-term changes in nutrition. Rev. Reprod. 1: 117-126.
47. SCAPAGNINI, U. & M. MATERA. 1997. Effects of pivagabine on psychophysical performance and behavioural response in experimental models of stress. Arznein Forsch Drug Res. 47: 1310-1317.
48. GIGLIOLI, B., A. MULTINU & V.R. LAI. 1997. Role of pivagabine in the treatment of climateric syndrome. Arzneim Forsch Drug Res. 47: 1317-1321.
49. BRITTON, K.T., G. LEE & G.F. KOOB. 1988. Corticotropin releasing factor and amphetamine exaggerate partial agonist properties of benzodiazepine antagonist Ro 15-1788 in the conflict test. Psychopharmacolgy 94: 306-311.
50. DE BOER, S.F., J.L. SLANGER & J. VAN DE GUTNER. 1995. Brain benzodiazepine receptor control of stress hormones. In Stress, Neuroendocrine and Molecular Approaches. R. Kvetnasky, R. Mc Carty, J. Axelrod, Eds.: 719-734. Gordon and Breach. New York, NY.
51. OWENS, M.J., G. BISSETTE & C.B. NEMEROFF. 1989. Acute effects of alprazolam and adinazolam on the concentrations of corticotropin-releasing factor in the rat brain. Synapse 4: 196-202.
52. BARBARINO, A., S.M. CORSELLO, S. DELLA CASA, et al. 1990. Corticotropin-releasing hormone inhibition of growth hormone-releasing hormone-induced growth hormone release in man. J. Clin. Endocrinol. Metab. 71: 1368-1374.
53. GENAZZANI, A.D., M. STOMATI, C. BERSI, et al. 2000. Pivagabine decreases stress-related hormone secretion in women with hypothalamic amenorrhea. J. Endocrinol. Invest. 23: 526-532.